Capillary Blood Collection Tubes Sales

Capillary Blood Collection Tubes Sales Market Outlook

The global capillary blood collection tubes market is anticipated to reach USD 1.2 billion by 2035, with a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2025 to 2035. This remarkable growth can be attributed to the rising demand for point-of-care testing and the increasing prevalence of chronic diseases which require regular monitoring. Furthermore, technological advancements in blood collection methods and the growing emphasis on reducing patient discomfort have significantly bolstered the market. The rising need for efficient diagnostic procedures and the expansion of healthcare infrastructure globally also play crucial roles in enhancing market dynamics. Additionally, the ongoing research and development efforts aimed at improving blood collection safety and efficiency propel the market forward.

Growth Factor of the Market

The growth of the capillary blood collection tubes market can be largely attributed to the increasing preference for minimally invasive procedures among healthcare providers and patients alike. As the need for quick and accurate diagnostics grows, healthcare professionals are increasingly turning to capillary blood collection methods, which reduce the need for venipuncture. Moreover, the rise in chronic diseases such as diabetes and cardiovascular disorders has led to a surge in routine blood testing, further fueling the demand for capillary blood collection tubes. Technological advancements in the manufacturing of these tubes, including the use of advanced materials that enhance stability and safety, have also contributed to the market's growth. In addition, the growing awareness about the importance of early disease detection has encouraged investments in healthcare infrastructure, leading to a higher demand for effective blood collection solutions. Lastly, the global shift towards home healthcare and self-testing solutions has created new opportunities for capillary blood collection tube manufacturers.

Key Highlights of the Market

• Projected market size of USD 1.2 billion by 2035.
• Significant CAGR of 7.5% expected between 2025 and 2035.
• Increasing demand for minimal invasive blood collection techniques.
• Rise in chronic diseases driving the need for regular blood testing.
• Technological advancements improving safety and efficiency in blood collection.

By Product Type

Serum Separating Tubes:

Serum separating tubes (SSTs) play a vital role in the clinical laboratory as they facilitate the efficient separation of serum from the blood sample. These tubes contain a gel that forms a barrier between the serum and the blood cells after centrifugation, thus preventing contamination. The rising prevalence of various diseases necessitating a serum analysis is expected to drive the demand for SSTs in the coming years. Additionally, their ease of use and ability to provide accurate results without the need for additional handling further enhance their popularity within the healthcare sector. As laboratories seek to streamline their processes and reduce the risk of cross-contamination, SSTs are poised to become a preferred choice for many practitioners.

Plasma Separating Tubes:

Plasma separating tubes (PSTs) are crucial for laboratories focusing on plasma analysis, as they ensure the separation of plasma from blood effectively. These tubes typically contain a gel separator that aids in the quick and efficient separation of plasma upon centrifugation. The growth in demand for plasma testing, particularly in the fields of biochemistry and hematology, is expected to drive the market for PSTs. Given the increasing number of diagnostic tests conducted in hospitals and laboratories, the preference for PSTs is anticipated to rise, as they facilitate rapid processing and improve turnaround times. Furthermore, advancements in materials used in PST manufacturing are likely to enhance their performance, thereby supporting their sustained market growth.

Heparin Tubes:

Heparin tubes are commonly used for collecting blood samples for various diagnostic tests that require anticoagulation. These tubes are particularly favored in situations where immediate plasma samples are necessary, as heparin prevents clotting effectively. The growing emphasis on timely diagnostics, especially in emergency and critical care settings, has led to an increased demand for heparin tubes. Additionally, as the healthcare system continues to evolve towards more immediate and precise testing, the role of heparin tubes becomes increasingly vital. Their ability to provide safety and efficiency in blood collection and processing will continue to drive demand and foster innovation within this product segment.

EDTA Tubes:

EDTA (ethylenediaminetetraacetic acid) tubes are predominantly used for hematology tests, as they effectively prevent clotting by chelating calcium ions in the blood. The rising incidence of blood-related disorders and the growing need for regular blood tests have contributed significantly to the demand for EDTA tubes. These tubes are essential for complete blood counts and are widely used in both hospital and laboratory settings. As healthcare providers increasingly prioritize accurate and timely hematological analyses, the use of EDTA tubes is expected to grow, enhancing the clinical capabilities of laboratories while ensuring reliable and reproducible results. Furthermore, innovation in the design and materials of EDTA tubes could lead to even better functionalities, promoting their usage in various diagnostic applications.

Glucose Tubes:

Glucose tubes specifically cater to the needs of testing blood glucose levels, making them indispensable in diabetes management and research. The prevalence of diabetes and related conditions has surged globally, creating a significant demand for accurate glucose testing devices and consumables. These tubes are designed to preserve glucose levels during sample transport and storage, ensuring reliable test outcomes. As public health initiatives focus on managing and controlling diabetes, the reliance on glucose tubes for both routine testing and research purposes is expected to increase. Manufacturers are likely to invest in the development of glucose tubes equipped with improved features, which will further solidify their position in the market.

By Application

Hospitals:

Hospitals are major end-users of capillary blood collection tubes due to the high volume of diagnostic tests conducted daily. These facilities rely on rapid and accurate blood sample collection to facilitate timely treatment decisions. The growing number of hospital admissions due to chronic diseases and emergencies drives the demand for efficient blood collection methods. Hospitals also require specialized tubes designed for particular tests, such as serum, plasma, and anticoagulated samples. As healthcare facilities continuously strive to enhance patient outcomes through improved diagnostics, the utilization of capillary blood collection tubes in hospital settings is expected to rise significantly, contributing to the overall growth of the market.

Clinics:

Clinics play a pivotal role in the capillary blood collection tubes market as they provide essential diagnostic services to patients. These facilities often serve as the first point of contact for individuals seeking medical attention, necessitating the availability of blood collection tubes for various tests. The increasing trend of outpatient care and preventive health screenings has further boosted the demand for capillary blood collection tubes in clinical environments. As clinics focus on providing efficient services with minimal discomfort to patients, the adoption of capillary blood collection methods is likely to rise, consequently increasing the need for appropriate blood collection tubes tailored to specific tests.

Diagnostic Centers:

Diagnostic centers are critical contributors to the capillary blood collection tubes market due to their specialized focus on laboratory testing and diagnostics. These centers cater to numerous patients requiring blood tests for various conditions, thus driving the demand for efficient blood collection solutions. The growing emphasis on early disease detection and preventive healthcare has led to a surge in the number of diagnostic tests performed. Consequently, diagnostic centers are increasingly adopting advanced capillary blood collection techniques, prompting the demand for specialized tubes. Furthermore, as technology advances and diagnostic capabilities improve, the market for capillary blood collection tubes within diagnostic centers is expected to expand significantly.

Blood Banks:

Blood banks are essential institutions that rely heavily on capillary blood collection tubes for efficient blood sample collection and processing. The growing need for blood donations and transfusions, particularly in emergency situations, has led to an increased emphasis on improving blood collection methods. Blood banks require tubes that facilitate safe and effective blood collection while maintaining sample integrity during storage. As the demand for donated blood continues to rise, blood banks are likely to adopt innovative solutions, including specialized capillary blood collection tubes that cater to their needs. The evolving landscape of blood banking and transfusion medicine is expected to drive further growth in this segment.

Others:

The "Others" application segment encompasses a variety of settings that utilize capillary blood collection tubes, including research laboratories, home healthcare, and veterinary clinics. As the importance of blood tests expands across different fields, the demand for capillary blood collection tubes in these sectors is anticipated to grow. Research laboratories often require specialized tubes for specific assays, while home healthcare solutions increasingly rely on convenient blood collection methods. Additionally, veterinary practices require effective blood sampling techniques for diagnosing animal health conditions, further driving the demand for capillary blood collection tubes in diverse applications. As innovations in blood collection technology continue to emerge, the market is expected to witness growth across all these varied settings.

By Distribution Channel

Hospital Pharmacies:

Hospital pharmacies serve as a key distribution channel for capillary blood collection tubes, providing essential supplies to various departments within healthcare facilities. These pharmacies ensure that hospitals have a constant supply of blood collection tubes to facilitate diagnostic testing and improve patient care. The high volume of tests conducted in hospitals necessitates an efficient supply chain for these essential items. Hospital pharmacies often work closely with manufacturers to ensure that they have the latest products that meet healthcare standards. As hospitals continue to enhance their diagnostic capabilities, the reliance on hospital pharmacies for capillary blood collection tubes is expected to grow, promoting market expansion.

Retail Pharmacies:

Retail pharmacies represent a significant distribution channel for capillary blood collection tubes, catering to the growing demand for at-home testing solutions. With an increasing number of patients managing chronic conditions like diabetes at home, the availability of capillary blood collection tubes in retail pharmacies has become essential. These pharmacies stock various types of blood collection tubes, enabling patients to conveniently access the products they need for self-testing. As consumer awareness about the importance of regular health monitoring rises, the demand for capillary blood collection tubes through retail pharmacies is projected to grow, fueling market expansion.

Online Sales:

Online sales have emerged as a crucial distribution channel for capillary blood collection tubes, driven by the convenience and accessibility offered to consumers. The increasing digitization of healthcare has led to a rise in online platforms where patients and healthcare providers can easily order blood collection tubes. This channel enables manufacturers to reach a broader audience and cater to the growing demand for home testing products. The COVID-19 pandemic has further accelerated the shift towards online shopping, as individuals seek to minimize in-person visits to pharmacies. As e-commerce continues to gain traction in healthcare, the online sales channel for capillary blood collection tubes is expected to experience substantial growth.

Direct Sales:

Direct sales involve manufacturers selling capillary blood collection tubes directly to healthcare facilities, laboratories, and other end-users. This distribution channel allows manufacturers to establish strong relationships with their clients while ensuring that they meet specific requirements for blood collection solutions. Direct sales often provide customers with the opportunity to receive tailored products that align with their operational needs. As healthcare facilities increasingly prioritize quality and reliability in their supplies, the direct sales approach is likely to gain traction in the capillary blood collection tubes market. Manufacturers focusing on building lasting partnerships with healthcare providers will find success in this distribution channel.

By Material Type

Glass:

Glass capillary blood collection tubes have long been a staple in laboratory settings due to their inert nature and ability to preserve sample integrity. These tubes are resistant to chemical interactions, making them ideal for a wide range of tests. The stability and durability of glass tubes allow for long-term storage without compromising the quality of the samples. However, glass tubes are heavier and more fragile compared to their plastic counterparts, which can pose challenges in handling and transportation. Nevertheless, the demand for glass capillary tubes remains strong in various diagnostic applications where sample accuracy and reliability are paramount. Innovations in glass manufacturing technology are likely to enhance the appeal of glass tubes, supporting their continued presence in the market.

Plastic:

Plastic capillary blood collection tubes have gained popularity due to their lightweight and shatterproof characteristics, making them safer and easier to handle than glass tubes. These tubes are often designed to be compatible with automated blood collection devices, enhancing their utility in fast-paced laboratory environments. The cost-effectiveness and versatility of plastic tubes have also driven their adoption in various healthcare settings. Furthermore, advancements in plastic materials have led to the development of tubes that minimize sample contamination and improve storage capabilities. As laboratories increasingly seek efficient and reliable blood collection solutions, the demand for plastic capillary blood collection tubes is expected to continue growing.

Silicone-Coated:

Silicone-coated capillary blood collection tubes are engineered to improve the efficiency of blood sample collection. The silicone coating on these tubes helps to prevent the adhesion of blood cells to the tube surface, thus enhancing sample recovery and minimizing the risk of contamination. This feature is particularly beneficial in applications where precise quantification of analytes is critical. The increasing need for accurate diagnostics and the growing emphasis on laboratory efficiency are likely to boost the demand for silicone-coated tubes. As healthcare providers prioritize the quality of test results, the silicone-coated capillary blood collection tubes market is poised for significant growth.

By Region

The North America region is poised to dominate the capillary blood collection tubes market, with a projected market value of approximately USD 450 million by 2035. Factors driving this growth include advanced healthcare infrastructure, increased healthcare expenditure, and a high prevalence of chronic diseases that necessitate frequent blood testing. The region is also home to several key manufacturers and research institutions that continuously innovate to enhance blood collection technology. Furthermore, the rising trend of point-of-care testing and the growing adoption of home diagnostic solutions contribute to the increasing demand for capillary blood collection tubes in North America.

Europe is another significant market for capillary blood collection tubes, expected to reach around USD 350 million by 2035, with a CAGR of 6.5% during the forecast period. The presence of a well-established healthcare system, coupled with the increasing focus on early disease detection and preventive healthcare, drives the demand for blood collection solutions in this region. Additionally, the growing number of diagnostic centers and hospitals adopting advanced blood testing techniques contributes to the expansion of the market. The rising awareness of the benefits associated with minimally invasive blood collection methods further supports market growth in Europe.

Opportunities

One of the primary opportunities in the capillary blood collection tubes market lies in the growing trend towards home healthcare and self-testing solutions. As more patients manage chronic illnesses at home, the demand for user-friendly blood collection devices has surged. Manufacturers have the chance to innovate and develop capillary blood collection tubes that cater to this growing market segment. By focusing on creating products that provide convenience and ease of use, companies can effectively capture a significant share of the home healthcare market. Moreover, partnerships with healthcare providers and technology companies can facilitate the development of integrated solutions that streamline the testing process, enhancing patient satisfaction and adherence to health monitoring.

Additionally, the rising focus on personalized medicine presents another opportunity for growth in the capillary blood collection tubes market. As healthcare shifts towards tailored treatment plans based on individual patient needs, there is an increasing demand for accurate and reliable diagnostic testing. Capillary blood collection tubes that enable precise testing and analysis of biomarkers can play a pivotal role in this evolving landscape. Manufacturers can invest in research and development to create specialized tubes designed for specific tests that cater to personalized medicine needs. By aligning their product offerings with the trend of individualized healthcare, companies can position themselves favorably in the market.

Threats

One of the significant threats to the capillary blood collection tubes market is the increasing competition from alternative blood collection methods. The emergence of advanced technologies, such as microfluidics and droplet-based assays, could potentially disrupt the traditional blood collection landscape. These alternative methods often offer advantages such as higher precision, reduced sample volumes, and faster turnaround times. As healthcare providers and laboratories seek to enhance their testing capabilities, they may opt for these innovative solutions over traditional capillary blood collection tubes. This shift could pose a challenge for manufacturers who need to differentiate their products and demonstrate their value in a competitive market.

Regulatory challenges represent another potential restraining factor for the capillary blood collection tubes market. The healthcare industry is subject to stringent regulations and standards concerning product safety, efficacy, and quality. Manufacturers must navigate complex regulatory pathways to ensure that their products comply with local and international standards. Any changes in regulatory requirements or delays in approval processes can significantly impact the market's growth. Furthermore, the need for continuous investment in quality assurance and compliance measures can strain the resources of companies operating in this sector, hindering their ability to innovate and meet market demands.

Competitor Outlook

• Becton, Dickinson and Company
• Terumo Corporation
• Greiner Bio-One International GmbH
• Fisher Scientific
• VWR International
• Cardinal Health
• Medline Industries, Inc.
• Sarstedt AG & Co.
• HemoCue AB
• Kabe Labortechnik GmbH
• Roche Diagnostics
• Sysmex Corporation
• Bio-Rad Laboratories
• Qiagen N.V.
• Avantor, Inc.

The capillary blood collection tubes market is characterized by a highly competitive landscape with numerous key players striving for market share. Companies are increasingly focusing on innovation and product differentiation to address the evolving needs of healthcare providers and patients. The competitive environment encourages collaborations and partnerships among manufacturers, distributors, and healthcare institutions to enhance product offerings and improve distribution channels. Furthermore, players are investing in research and development to introduce advanced capillary blood collection solutions that enhance accuracy, safety, and patient comfort. As a result, the competitive landscape is expected to evolve, with companies continuously adapting to market dynamics to stay ahead of the curve.

Among the major companies in the capillary blood collection tubes market, Becton, Dickinson and Company stands out as a leading player known for its extensive portfolio of medical devices and diagnostics. With a strong emphasis on research and development, Becton, Dickinson has introduced innovative blood collection solutions that cater to various clinical needs. The company's commitment to quality and safety has solidified its reputation as a trusted provider in the healthcare industry, positioning it well for sustained growth in the capillary blood collection tubes market.

Greiner Bio-One International GmbH is another key competitor recognized for its innovative blood collection products. The company has made significant strides in improving the design and functionality of blood collection tubes, enhancing their usability for healthcare professionals. Greiner Bio-One's focus on customer satisfaction and adherence to strict quality standards has contributed to its success in the capillary blood collection tubes market. As the demand for advanced blood collection solutions continues to rise, the company's strong market presence and commitment to innovation position it favorably for future growth.

Terumo Corporation has also established itself as a prominent player in the capillary blood collection tubes market. With a diverse product portfolio that includes blood collection and transfusion solutions, Terumo emphasizes technological advancements and user-friendly designs. The company has invested significantly in research and development to create high-quality blood collection tubes that meet the evolving needs of healthcare providers. Terumo's commitment to continuous improvement and its ability to respond to changing market demands contribute to its competitive edge within the industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 HemoCue AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Qiagen N.V.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Avantor, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Cardinal Health
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Fisher Scientific
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Sarstedt AG & Co.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 VWR International
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Sysmex Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Terumo Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Kabe Labortechnik GmbH
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Medline Industries, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Becton, Dickinson and Company
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Greiner Bio-One International GmbH
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Capillary Blood Collection Tubes Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Diagnostic Centers
    • 6.1.4 Blood Banks
    • 6.1.5 Others
  • 6.2 Capillary Blood Collection Tubes Sales Market, By Product Type
    • 6.2.1 Serum Separating Tubes
    • 6.2.2 Plasma Separating Tubes
    • 6.2.3 Heparin Tubes
    • 6.2.4 EDTA Tubes
    • 6.2.5 Glucose Tubes
  • 6.3 Capillary Blood Collection Tubes Sales Market, By Material Type
    • 6.3.1 Glass
    • 6.3.2 Plastic
    • 6.3.3 Silicone-Coated
  • 6.4 Capillary Blood Collection Tubes Sales Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Sales
    • 6.4.4 Direct Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Capillary Blood Collection Tubes Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Capillary Blood Collection Tubes Sales market is categorized based on

By Product Type

• Serum Separating Tubes
• Plasma Separating Tubes
• Heparin Tubes
• EDTA Tubes
• Glucose Tubes

By Application

• Hospitals
• Clinics
• Diagnostic Centers
• Blood Banks
• Others

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Sales
• Direct Sales

By Material Type

• Glass
• Plastic
• Silicone-Coated

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Becton, Dickinson and Company
• Terumo Corporation
• Greiner Bio-One International GmbH
• Fisher Scientific
• VWR International
• Cardinal Health
• Medline Industries, Inc.
• Sarstedt AG & Co.
• HemoCue AB
• Kabe Labortechnik GmbH
• Roche Diagnostics
• Sysmex Corporation
• Bio-Rad Laboratories
• Qiagen N.V.
• Avantor, Inc.